Cigna Reports Strong First Quarter 2016 Results, Raises Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Cigna Corp (CI) Lower Probability of ANTM Deal Closing - Jefferies
May 9, 2016 9:38 AM EDTJefferies analyst, David Windley, thinks CIGNA (NYSE: CI) is attractive despite temporarily weaker disability revenue in the quarter. No change to Buy rating but the PT drops on lower probability of deal closure.
Strong core results in the Healthcare business reinforce our view that owning CI is an attractive risk reward. Disability was weaker, but should quickly rebound this... More
Cigna Corp (CI) Core Healthcare Segment Solid - Leerink
May 9, 2016 8:57 AM EDTLeerink Partners analyst, Ana Gupte, maintained her Outperform rating and $175 PT after CIGNA (NYSE: CI) posted a strong "Beat and Raise" 1Q. The beat was offset by weakness in Group Life and Disability segment due to modifications in claims management processes resulting... More
Cigna Corp. (CI) Tops Q1 EPS by 16c; Boosts FY16 EPS Outlook
May 6, 2016 6:01 AM EDTCigna Corp. (NYSE: CI) reported Q1 EPS of $2.32, $0.16 better than the analyst estimate of $2.16. Revenue for the quarter came in at $9.9 billion versus the consensus estimate of $9.98 billion.
GUIDANCE:
Cigna Corp. sees FY2016 EPS of $8.95-$9.35, versus the consensus of... More
